FM
Fady Ibraham Malik
EVP Research & Development

Fady Ibraham Malik insider trades: Cytokinetics (CYTK) stock sales

EVP Research & Development, Cytokinetics Last trade Nov 3, 2026 162 Form 4 filings
$4.4M
Sold, last 12 months
17 sales
$0
Bought, last 12 months
0 buys
122
Open-market trades
since 2014
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Fady reports to the SEC

Open-market buys and sales

122 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026CYTK↓ Sell$220K
Oct 20, 2026CYTK↓ Sell$224K
Oct 6, 2026CYTK↓ Sell$215K
Sep 22, 2026CYTK↓ Sell$239K
Sep 8, 2026CYTK↓ Sell$264K
Jul 21, 2026CYTK↓ Sell$282K
Jul 7, 2026CYTK↓ Sell$303K
Jun 23, 2026CYTK↓ Sell$278K
Jun 9, 2026CYTK↓ Sell$238K
May 19, 2026CYTK↓ Sell$265K
May 5, 2026CYTK↓ Sell$271K
Apr 7, 2026CYTK↓ Sell$293K
Mar 17, 2026CYTK↓ Sell$748K
Mar 9, 2026CYTK↓ Sell$177K
Dec 16, 2025CYTK↓ Sell$135K
Dec 2, 2025CYTK↓ Sell$141K
Nov 18, 2025CYTK↓ Sell$146K
Nov 4, 2025CYTK↓ Sell$137K
Oct 21, 2025CYTK↓ Sell$123K
Oct 7, 2025CYTK↓ Sell$121K
Sep 23, 2025CYTK↓ Sell$99K
Sep 9, 2025CYTK↓ Sell$103K
Aug 19, 2025CYTK↓ Sell$77K
Aug 5, 2025CYTK↓ Sell$73K
Jul 22, 2025CYTK↓ Sell$75K
Jul 8, 2025CYTK↓ Sell$68K
Jun 17, 2025CYTK↓ Sell$66K
Jun 3, 2025CYTK↓ Sell$64K
May 20, 2025CYTK↓ Sell$64K
May 6, 2025CYTK↓ Sell$70K
Apr 22, 2025CYTK↓ Sell$76K
Apr 8, 2025CYTK↓ Sell$72K
Mar 18, 2025CYTK↓ Sell$87K
Mar 17, 2025CYTK↓ Sell$195K
Mar 6, 2025CYTK↓ Sell$356K
Mar 4, 2025CYTK↓ Sell$85K
Mar 3, 2025CYTK↓ Sell$105K
Feb 18, 2025CYTK↓ Sell$92K
Feb 4, 2025CYTK↓ Sell$96K
Jan 21, 2025CYTK↓ Sell$92K
Jan 7, 2025CYTK↓ Sell$99K
Dec 10, 2024CYTK↓ Sell$370K
Nov 26, 2024CYTK↓ Sell$366K
Nov 12, 2024CYTK↓ Sell$371K
Oct 30, 2024CYTK↓ Sell$379K
Oct 15, 2024CYTK↓ Sell$396K
Oct 1, 2024CYTK↓ Sell$380K
Sep 17, 2024CYTK↓ Sell$414K
Sep 3, 2024CYTK↓ Sell$421K
Aug 20, 2024CYTK↓ Sell$411K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CYTK insiders

Open-market trades in the last 12 months

About Fady Ibraham Malik's insider trades

Fady Ibraham Malik is EVP Research & Development at Cytokinetics (CYTK). Since Dec 30, 2014, Fady has reported no open-market purchases and 122 sales worth $33.2M on SEC Form 4. In the last 12 months: 17 sales ($4.4M).

Their filings also include option exercises (69 filings), grants and awards (22 filings), shares withheld for taxes (19 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.